[PDF][PDF] 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the …
…, HE Paulus, M Suarez‐Almazor… - Arthritis care & …, 2012 - Wiley Online Library
The American College of Rheumatology (ACR) most recently published recommendations
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
for the use of diseasemodifying antirheumatic drugs (DMARDs) and biologic agents in the …
Immune-related adverse events of checkpoint inhibitors
…, X Mariette, A Prat, ME Suárez-Almazor - Nature reviews Disease …, 2020 - nature.com
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication?
…, LA Petersen, BF Sharf, ME Suarez-Almazor… - Journal of general …, 2003 - Springer
African Americans and Latinos use services that require a doctor’s order at lower rates than
do whites. Racial bias and patient preferences contribute to disparities, but their effects …
do whites. Racial bias and patient preferences contribute to disparities, but their effects …
Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update
…, JM Song, A Spira, M Suarez-Almazor… - Journal of clinical …, 2021 - ingentaconnect.com
PURPOSE To increase awareness, outline strategies, and offer guidance on the recommended
management of immune-related adverse events (irAEs) in patients treated with immune …
management of immune-related adverse events (irAEs) in patients treated with immune …
[HTML][HTML] Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical …
…, C Seigel, A Spira, ME Suarez-Almazor… - Journal of clinical …, 2018 - ncbi.nlm.nih.gov
Purpose To increase awareness, outline strategies, and offer guidance on the recommended
management of immune-related adverse events in patients treated with immune …
management of immune-related adverse events in patients treated with immune …
International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001
…, AM Prieur, ME Suarez-Almazor… - The Journal of …, 2004 - pubmed.ncbi.nlm.nih.gov
… 1 , Taunton R Southwood, Prudence Manners, John Baum, David N Glass, Jose
Goldenberg, Xiaohu He, Jose Maldonado-Cocco, Javier Orozco-Alcala, Anne-Marie Prieur …
Goldenberg, Xiaohu He, Jose Maldonado-Cocco, Javier Orozco-Alcala, Anne-Marie Prieur …
Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997
…, J Maldonado-Cocco, M Suarez-Almazor… - Journal of …, 1998 - api.taylorfrancis.com
For many years a united international classification for chronic childhood arthritis has been
absent. The lack of consensus has led to difficulties in trial structure and data interpretation. …
absent. The lack of consensus has led to difficulties in trial structure and data interpretation. …
[HTML][HTML] Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity …
…, AW Silk, D Skondra, ME Suarez-Almazor… - … for immunotherapy of …, 2017 - Springer
Cancer immunotherapy has transformed the treatment of cancer. However, increasing use
of immune-based therapies, including the widely used class of agents known as immune …
of immune-based therapies, including the widely used class of agents known as immune …
[HTML][HTML] Understanding the pain experience in hip and knee osteoarthritis–an OARSI/OMERACT initiative
…, JM Jordan, L March, M Suarez-Almazor… - Osteoarthritis and …, 2008 - Elsevier
OBJECTIVE: To examine the pain experience of people with hip or knee osteoarthritis (OA),
particularly changes over time and most distressing features. METHOD: Focus groups in …
particularly changes over time and most distressing features. METHOD: Focus groups in …
Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study
…, J Hanson, ME Suarez-Almazor… - Archives of internal …, 2000 - jamanetwork.com
… M Counselling the confused patient and the family. Portenoy … of Public Health Services (Dr
Suarez-Almazor), University of … M Counselling the confused patient and the family. Portenoy …
Suarez-Almazor), University of … M Counselling the confused patient and the family. Portenoy …